Changes in Biomodels in Response to Recombinant Protective Anthrax Antigen Inoculation
https://doi.org/10.21055/0370-1069-2013-4-106-109
Abstract
one. The data obtained has substantiated the lack of an expressed damaging effect of the recombinant protective antigen on the cells and tissues of the macroorganism, as well as possibility of its application as one of the core components of the chemical anthrax vaccine.
About the Authors
P. Yu. Popova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
S. A. Bugorkova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
N. I. Mikshis
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
A. P. Semakova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
Yu. A. Popov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
T. N. Shchukovskaya
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
References
1. Korzhevsky D.E., Gilyarov A.V. [Fundamental Principles of Histological Technique]. St. Petersburg; 2010. 96 p.
2. Mikshis N.I., Kudryavtseva O.M., Bolotnikova M.F., Shulepov D.V., Novikova L.V., Popov Yu.A., Shchukovskaya T.N., Drozdov I.G., Kutyrev V.V. [Immunogenicity of recombinant bacilli strains with cloned gene responsible for Bacillus anthracis protective antigen synthesis]. Mol. Genet. Mikrobiol. Virusol. 2007; 3:15–21.
3. National Research Council. [Guidelines on care and use of laboratory animals]. Washington: National Academy; 1996.
4. [Basic requirements to anthrax microbe vaccine strains used for immunization of humans]. Methodological recommendations. MR 3.3.1.1112-02. M.; 2002. 47 p.
5. Popova P.Yu., Mikshis N.I., Kudryavtseva O.M., Goncharova A.Yu., Novikova L.V., Kashtanova T.N., Popov Yu.A., Smol’kova E.A., Kravtsov A.L., Shchukovskaya T.N.[Influence of the protective antigen, produced by Bacillus anthracis asporogenic recombinant strain, on the immune system of laboratory animals]. Probl. Osobo Opasn. Infek. 2012; 1(111):84–7.
6. Bashir M.E., Louie S., Shi H.N., Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 2004; 172:6978–87.
7. Chitlaru T., Altboum Z., Reuveny S., Shafferman A. Progress and novel strategies in vaccine development and treatment of anthrax. Immunol. Rev. 2011; 239(1):221–36.
8. Eisenbarth S., Piggott D., Huleatt J., Visintin I., Herrick C., Bottomly K. Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen. J. Exp. Med. 2002; 196(12):1645–51.
9. Fellows P., Linscott M., Ivins B., Pitt M., Rossi C., Gibbs P., Friedlander A. Efficacy of a human anthrax vaccine in guinea pigs, rabbits and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine. 2001; 19:3241–7.
10. Goossens P. Animal models of human anthrax: the quest for the Holy Grail. Mol. Aspects Med. 2009; 30(6):467–80.
11. Ivins B., Fellows P., Nelson G. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1994; 12(10): 872–4.
12. Scorpio A., Blank T., Day W., Chabot D. Anthrax vaccines: Pasteur to present. Cell Mol. Life Sci. 2006; 63:2237–48.
Review
For citations:
Popova P.Yu., Bugorkova S.A., Mikshis N.I., Semakova A.P., Popov Yu.A., Shchukovskaya T.N. Changes in Biomodels in Response to Recombinant Protective Anthrax Antigen Inoculation. Problems of Particularly Dangerous Infections. 2013;(4):106-109. (In Russ.) https://doi.org/10.21055/0370-1069-2013-4-106-109
Views:
614
Email this article 